Full Text View
Tabular View
No Study Results Posted
Related Studies
Memantine for Agitation in Dementia (MAGD)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by East Kent Hospitals University NHS Foundation Trust.
Recruitment status was  Recruiting
Study NCT00371059   Information provided by East Kent Hospitals University NHS Foundation Trust

First Received on August 30, 2006.   Last Updated on May 7, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dementia
Additional conditions recognized in this trial
Psychomotor Agitation
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dyskinesias
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Psychomotor Disorders
Signs and Symptoms
Interventions listed in this trial
Memantine
Placebo
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
East Kent Hospitals University NHS Foundation Trust
University of Oxford
Institute of Psychiatry, London
University of London
University College, London
Indiana University School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services